Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buparid/PARI SINUS versus Budes nasal spray for chronic rhinosinusitis with nasal polyps
2013-002414-12Phase 2Completed
- Sponsor
- PARI Pharma
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Buparid and budesonide in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by PARI Pharma. Primary endpoint: Efficacy. Started Sep 2013; status: completed.
02
Drugs
Buparidbudesonide
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on 2013-002414-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002414-12.